Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth

BACKGROUND: The altered gut microbiota is implicated in the pathogenesis of liver fibrosis. Resveratrol is a candidate for the treatment of liver fibrosis, which could ameliorate the dysregulation of gut microbiota in mice. This study aimed to clarify the role and mechanism of resveratrol in gut mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiqin, Dong, Jianxia, Wang, Meng, Yan, Jingya, Hu, Yushu, Liu, Yang, Pan, Yajie, Li, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066969/
https://www.ncbi.nlm.nih.gov/pubmed/35508992
http://dx.doi.org/10.1186/s10020-022-00463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066969/
https://www.ncbi.nlm.nih.gov/pubmed/35508992
http://dx.doi.org/10.1186/s10020-022-00463-y

Ejemplares similares